Description
Manufacturer
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Attruby (acoramidis)
$10,000.00
Attruby (acoramidis) is a prescription treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults 1.
Attruby (acoramidis) is approved in the USA 2.
Additional information
| Package | 112 tablets x 356 mg |
|---|
Related products
-
Nexletol (bempedoic acid)
$400.00 Select options This product has multiple variants. The options may be chosen on the product page -
Vascepa (icosapent ethyl)
$700.00 Select options This product has multiple variants. The options may be chosen on the product page -
Orladeyo (berotralstat)
Price range: $14,000.00 through $50,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Verquvo (vericiguat)
Price range: $100.00 through $350.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.